Effect of tocilizumab in hospitalized patients with severe pneumonia COVID-19: a cohort study
Benjamin Rossi, View ORCID ProfileLee S. Nguyen, Philippe Zimmermann, Faiza Boucenna, Louis Dubret, Louise Baucher, Helene Guillot, Marie-Anne Bouldouyre, View ORCID ProfileYves Allenbach, Joe-Elie Salem, Paul Barsoum, Arezki Oufella, Helene Gros
doi: https://doi.org/10.1101/2020.06.06.20122341
Benjamin Rossi
1Department of Internal Medicine, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
Lee S. Nguyen
2Research & innovation of CMC Ambroise Paré, 92200 Neuilly-sur-Seine, France
3Sorbonne Université, INSERM, Clinical Investigations Center Paris-Est, CIC-1901, AP.HP.6 Pitié-Salpétrière, 75013 Paris, France
Philippe Zimmermann
4Department of pharmacy, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
Faiza Boucenna
1Department of Internal Medicine, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
Louis Dubret
4Department of pharmacy, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
Louise Baucher
1Department of Internal Medicine, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
Helene Guillot
1Department of Internal Medicine, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
Marie-Anne Bouldouyre
1Department of Internal Medicine, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
Yves Allenbach
5Sorbonne Université, Department of Internal medicine and Clinical Immunology, AP.HP.6 Pitié-Salpétrière, 75013 Paris, France
Joe-Elie Salem
3Sorbonne Université, INSERM, Clinical Investigations Center Paris-Est, CIC-1901, AP.HP.6 Pitié-Salpétrière, 75013 Paris, France
Paul Barsoum
6Department of cardiology, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
Arezki Oufella
4Department of pharmacy, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
Helene Gros
1Department of Internal Medicine, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France

Data Availability
data are not available
Posted June 09, 2020.
Effect of tocilizumab in hospitalized patients with severe pneumonia COVID-19: a cohort study
Benjamin Rossi, Lee S. Nguyen, Philippe Zimmermann, Faiza Boucenna, Louis Dubret, Louise Baucher, Helene Guillot, Marie-Anne Bouldouyre, Yves Allenbach, Joe-Elie Salem, Paul Barsoum, Arezki Oufella, Helene Gros
medRxiv 2020.06.06.20122341; doi: https://doi.org/10.1101/2020.06.06.20122341
Effect of tocilizumab in hospitalized patients with severe pneumonia COVID-19: a cohort study
Benjamin Rossi, Lee S. Nguyen, Philippe Zimmermann, Faiza Boucenna, Louis Dubret, Louise Baucher, Helene Guillot, Marie-Anne Bouldouyre, Yves Allenbach, Joe-Elie Salem, Paul Barsoum, Arezki Oufella, Helene Gros
medRxiv 2020.06.06.20122341; doi: https://doi.org/10.1101/2020.06.06.20122341
Subject Area
Subject Areas
- Addiction Medicine (179)
- Allergy and Immunology (434)
- Anesthesia (99)
- Cardiovascular Medicine (948)
- Dermatology (110)
- Emergency Medicine (260)
- Epidemiology (8987)
- Gastroenterology (420)
- Genetic and Genomic Medicine (1959)
- Geriatric Medicine (190)
- Health Economics (402)
- Health Informatics (1329)
- Health Policy (660)
- Hematology (212)
- HIV/AIDS (420)
- Medical Education (200)
- Medical Ethics (54)
- Nephrology (222)
- Neurology (1830)
- Nursing (110)
- Nutrition (274)
- Oncology (999)
- Ophthalmology (298)
- Orthopedics (111)
- Otolaryngology (182)
- Pain Medicine (126)
- Palliative Medicine (44)
- Pathology (265)
- Pediatrics (580)
- Primary Care Research (234)
- Public and Global Health (4123)
- Radiology and Imaging (676)
- Respiratory Medicine (549)
- Rheumatology (225)
- Sports Medicine (177)
- Surgery (207)
- Toxicology (39)
- Transplantation (109)
- Urology (81)